Subscribe To Our Free Newsletter |
Param Desai’s 4 top picks in largecap and midcap pharma
“We believe that Cipla’s Pithampur facility was inspected in February and post that, they got an OAI in August and post that, it has escalated to a warning letter. We believe that it is unlikely that this will escalate further to import alerts, though this may take some time to resolve.”